TheEdgeResearch
Home / Stocks / ERMA.ST

Enorama Pharma AB (publ) (ERMA.ST)

STO Healthcare Medical - Pharmaceuticals
$0.67 ▼ -4.57%
Market Cap
$49.8M
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.80
52-Wk Range
0.211-3
CEO
Bengt Jönsson
Country
SE
Currency
SEK

Enorama Pharma AB (publ) operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Stockholm, AB, SE. The stock last traded at $0.67, down 4.57% on the session, giving a market capitalisation of $49.8M. Its beta of 1.80 implies it has historically moved more than the broad market.

Company profile
Exchange
Stockholm Stock Exchange
Employees
4
IPO date
2016-06-10
Headquarters
Stockholm, AB, SE
About Enorama Pharma AB (publ)

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.

Comparable companies

Enorama Pharma AB (publ) is most often compared with the following Healthcare names:

ACUC.STALZCUR.STANNX.STCLS-B.STINTEG-B.STISOFOL.STIZAFE-B.STKLAR.STSENZA.STVIVE.ST
More research on ERMA.ST
ERMA.ST technical analysis ERMA.ST TheEdge Score Compare against peers
Open full interactive analysis & DCF →